NCT00199654

Methods	This is a phase III open‐labelled, multicentre, multidisciplinary, randomised study, comparing 2 arms of 188 participants (i.e. 376 total participants).
Participants	Inclusion criteria Signed and dated written informed consent Confirmed stage II or III (TNM) Participant with curative surgery for colorectal adenocarcinoma Total digestive endoscopy prior surgery or postsurgery Age > 18 years old Normal liver ultrasound and chest X‐ray or thoraco‐abdomino pelvic computed tomography (CT) scan In fertile women, efficient contraception or postmenopausal participant (amenorrhoea for at least 1 year) Exclusion criteria Serious concomitant pathology Uncontrolled diabetes with a classical treatment (glycaemia > 1.4 g/l) Other malignancy within the last 5 years (except for curatively treated basocellular carcinoma of the skin or in situ cervical carcinoma) Uncontrolled infection Women who are pregnant or lactating Inability to understand informed consent Psychological or geographic impossibility to follow up for 3 years
Interventions	PET
Outcomes	Evaluation of overall survival in the 2 groups Evaluation of the rate of curative surgery Comparison of the medical cost in the 2 detection strategies
Notes	Study start date: February 2004 Study completion date: April 2013 No study results are published yet.